Understand the source comparison
Best Peptides to Improve Sleep Quality Ranked: Evidence-Based Comparison
Before selecting a peptide, researchers must match the compound's mechanism to the specific sleep disruption pattern under investigation. The table below ranks peptides by primary mechanism, strength of clinical evidence, and practical application context. Epi
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before selecting a peptide, researchers must match the compound's mechanism to the specific sleep disruption pattern under investigation. The table below ranks peptides by primary mechanism, strength of clinical evidence, and practical application context.
- Epitalon
- Pineal gland melatonin synthesis, circadian phase reset
- Moderate. Multiple animal studies, limited human RCTs
- 5–10 mg subcutaneous, 10-day cycles
- Circadian misalignment, jet lag models, aging-related melatonin decline
- Gold standard for circadian restoration research. Phase-resetting capacity unmatched by other peptides
- DSIP
- HPA axis modulation, delta-wave sleep enhancement
- Strong. Human polysomnography data, cortisol reduction confirmed
- 1–3 mg intramuscular or subcutaneous nightly
- Stress-driven insomnia, non-restorative sleep, middle-of-night awakening models
- Most versatile sleep peptide. Addresses both stress hormones and sleep architecture directly
- Pinealon
- Pineal cell gene expression, melatonin amplitude increase
- Moderate. Animal bioregulator studies, gerontology research
- 10–20 mg oral or sublingual, 30-day cycles
- Low melatonin amplitude without circadian phase shift, aging models
- Complements Epitalon when melatonin synthesis capacity (not timing) is the limiting factor
- Cerebrolysin
- Neuroinflammation suppression, BDNF/NGF support
- Strong. Multiple human trials in neurodegenerative contexts
- 5–10 mL intramuscular 2–3x weekly
- Neuroinflammation-driven sleep fragmentation, post-TBI sleep disturbance models
- Long-term foundational support. Not an acute sleep aid, but essential for inflammatory modulation
- Selank
- GABAergic anxiolysis, pre-sleep arousal reduction
- Moderate. Human anxiety trials, subjective sleep quality data
- 300–600 mcg intranasal or subcutaneous
- Sleep-onset insomnia driven by cognitive hyperarousal
- Effective for pre-sleep anxiety but doesn't improve objective sleep architecture
- Dihexa
- HGF mimetic, synaptogenesis and synaptic repair
- Limited. Strong animal data, minimal human sleep-specific trials
- 5–10 mg oral daily
- Synaptic dysfunction models, aging-related sleep fragmentation
- Neuroprotective rather than sleep-specific. Best as adjunct in long-term cognitive health protocols